This is a limited company view. Sign up for a Free Trial to see everything.

Debiopharm Group(tm) (Debiopharm) is a Swiss-based global biopharmaceutical group of companies with a focus on the development of innovative prescription drugs that target unmet medical needs. Oncology is the group's main area of expertise. In addition, Debiopharm develops drugs for specific indications in the following therapeutic areas: oncology, infectious diseases and orphan drugs.

B2B
Biotechnology
Cleantech
Healthcare
Pharmaceuticals
Wind Power

Overview

Location

Lausanne

Founded

1979

Employees

201

Stage

No Known Funding

Total funding

Undisclosed

Last funding

Acquisitions

1

Growth score

185

Mindshare score

185

Scoring

Deals

No funding events found.

Employee Growth

Use Debiopharm Group's historical employee count to better understand their growth and spending over time.

Unlock with a Free Trial

Mobile

Use Debiopharm Group's mobile downloads and app ranks to evaluate the performance of their mobile apps.

Unlock with a Free Trial

Key People

Director, Translational Laboratory
Director Legal Affairs and Member of the Executive Committee
Diagnostics Project Manager
Senior Clinical Trial Manager
Director Private Equity Department - Associate Director Private Equity Department
Medical Director
Director, Pharmacology and Screening
Director, Personalized Medicine
Drug Discovery Project Leader - Portfolio & Project Management Office
Quality Assurance Manager
VP, Medical Affairs
Associate Director, Clin Pharm & Drug Metabolism
Applied Bioresearch Manager - Translational Medecine
Health, Safety and Environment manager
Medical Director, Clinical Pharmacology
Medical Director
Regulatory Affairs Manager
Clinical trial associate manager

Similar Companies

Cardio3 BioSciences

Cardio3 BioSciences is focused on R&D and commercialization of regenerative and protective therapies for cardiovascular diseases.
Late|94 employees

Gain context with Mattermark Salesforce Enrichment

Find out how

Notes